Patel, RK;
Fontana, M;
Ruberg, FL;
(2021)
Cardiac Amyloidosis Multimodal Imaging of Disease Activity and Response to Treatment.
Circulation: Cardiovascular Imaging
, 14
(6)
, Article e009025. 10.1161/CIRCIMAGING.121.009025.
Preview |
Text
Fontana_Cardiac Amyloidosis Multimodal Imaging of Disease Activity and Response to Treatment_AAM.pdf - Accepted Version Download (288kB) | Preview |
Preview |
Image
Figure 1 - Cardiac Amyloidosis - Multi-modal Imaging.tif - Accepted Version Download (1MB) | Preview |
Preview |
Image
Figure 2 - Cardiac Amyloidosis - Multi-modal Imaging.tif - Accepted Version Download (1MB) | Preview |
Preview |
Image
Figure 3 - Cardiac Amyloidosis - Multi-modal Imaging.tif - Accepted Version Download (755kB) | Preview |
Preview |
Image
Figure 4 - Cardiac Amyloidosis - Multi-modal Imaging.tif - Accepted Version Download (97kB) | Preview |
Abstract
Cardiac amyloidosis (CA) is a disease characterized by the deposition of misfolded protein deposits in the myocardial interstitium. Although advanced CA confers significant morbidity and mortality, the magnitude of deposition and ensuing clinical manifestations vary greatly. Thus, an improved understanding of disease pathogenesis at both cellular and functional levels would afford critical insights that may improve outcomes. This review will summarize contemporary therapies for the 2 major types of CA, transthyretin and light chain amyloidosis, and outline the capacity of imaging modalities to both diagnose CA, inform prognosis, and follow response to available therapies. We explore the current landscape of echocardiography, cardiac magnetic resonance, and bone scintigraphy in the assessment of functional and cellular parameters of dysfunction in CA throughout disease pathogenesis. Finally, we examine the impact of concurrent advances in both therapeutics and imaging on future research questions that improve our understanding of underlying disease mechanisms. Multimodal imaging in CA affords an indispensable tool to offer individualized treatment plans and improve outcomes in patients with CA.
| Type: | Article |
|---|---|
| Title: | Cardiac Amyloidosis Multimodal Imaging of Disease Activity and Response to Treatment |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1161/CIRCIMAGING.121.009025 |
| Publisher version: | https://doi.org/10.1161/CIRCIMAGING.121.009025 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10131060 |
Archive Staff Only
 |
View Item |
